Australian Clinical Labs LtdASX: ACL

Appendix 4E and FY26 financial reports

· Issued by Australian Clinical Labs Ltd

Filed with ASX · · 117 pages · English

Summary by 6ix AI

The report highlights a slight decrease in total revenue compared to the previous year, alongside a notable decline in statutory profit attributable to members. The company declared a final fully franked dividend, reflecting its commitment to returning value to shareholders.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Australian Clinical Labs Ltd on 6ix

Earlier from Australian Clinical Labs

All Australian Clinical Labs news releases